Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

 1,868.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 26,151
  • Market Cap: £1,233.49m
  • RiskGrade: 128

Wednesday broker round-up

By Caoimhe Toman

Date: Wednesday 25 Nov 2020

LONDON (ShareCast) - (Sharecast News) - Codemasters Group: Berenberg downgrades to hold with a target price of 485p.



Pets at Home: Berenberg reiterates buy with a target price of 480p.

Vistry Group: Canaccord reiterates buy with a target price of 880p.

Brewin Dolphin: Canaccord reiterates buy with a target price of 335p.

AO World: JP Morgan reiterates neutral with a target price of 225p.

Auto Trader: JP Morgan reiterates underweight with a target price of 420p.

Sage Group: Citigroup reiterates neutral.

Pennon Group: Barclays reiterates equal weight with a target price of 1,060p.

Compass Group: Barclays reiterates overweight with a target price of 1,500p.

Petrofac: RBC Capital Markets reiterates sector perform with a target price of 255p.

Forterra: Deutsche Bank reiterates buy with a target price of 259p.

Glencore: Deutsche Bank reiterates buy with a target price of 250p.

Genus: Liberum reiterates buy with a target price of 4,490p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,868.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 26,151
Shares Issued 66.03m
Market Cap £1,233.49m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average53.64% below the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Income
86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average86.4% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 14-May-2024

Time Volume / Share Price
10:09 3 @ 1,868.00p
10:09 23 @ 1,868.00p
10:09 23 @ 1,866.00p
10:09 77 @ 1,868.00p
10:09 1 @ 1,868.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page